Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians.
Sato Y, Atarashi K, Plichta DR, Arai Y, Sasajima S, Kearney SM, Suda W, Takeshita K, Sasaki T, Okamoto S, Skelly AN, Okamura Y, Vlamakis H, Li Y, Tanoue T, Takei H, Nittono H, Narushima S, Irie J, Itoh H, Moriya K, Sugiura Y, Suematsu M, Moritoki N, Shibata S, Littman DR, Fischbach MA, Uwamino Y, Inoue T, Honda A, Hattori M, Murai T, Xavier RJ, Hirose N, Honda K. Sato Y, et al. Among authors: uwamino y. Nature. 2021 Nov;599(7885):458-464. doi: 10.1038/s41586-021-03832-5. Epub 2021 Jul 29. Nature. 2021. PMID: 34325466
Antiviral humoral immunity against SARS-CoV-2 omicron subvariants induced by XBB.1.5 monovalent vaccine in infection-naive and XBB-infected individuals.
Kosugi Y, Kaku Y, Hinay AA Jr, Guo Z, Uriu K, Kihara M, Saito F, Uwamino Y, Kuramochi J, Shirakawa K, Takaori-Kondo A; Genotype to Phenotype Japan (G2P-Japan) Consortium; Sato K. Kosugi Y, et al. Among authors: uwamino y. Lancet Infect Dis. 2024 Mar;24(3):e147-e148. doi: 10.1016/S1473-3099(23)00784-3. Epub 2024 Jan 8. Lancet Infect Dis. 2024. PMID: 38211599 No abstract available.
Comparing minimum inhibitory concentrations of amikacin for pulmonary Mycobacterium avium complex disease: An analysis of culture media differences.
Morita A, Namkoong H, Uwamino Y, Mitarai S, Aono A, Asakura T, Yagi K, Tanaka H, Azekawa S, Nakagawara K, Kaji M, Nagao G, Kamata H, Matsushita H, Fukunaga K, Hasegawa N. Morita A, et al. Among authors: uwamino y. J Infect Chemother. 2024 Feb;30(2):159-163. doi: 10.1016/j.jiac.2023.09.016. Epub 2023 Sep 16. J Infect Chemother. 2024. PMID: 37717608
Seroprevalence of severe acute respiratory syndrome coronavirus 2 N antibodies between December 2021 and march 2023 in Japan.
Yamayoshi S, Nagai E, Mitamura K, Hagihara M, Kobayashi R, Takahashi S, Shibata A, Uwamino Y, Hasegawa N, Iqbal A, Kamimaki I, Iwatsuki-Horimoto K, Nagamura-Inoue T, Kawaoka Y. Yamayoshi S, et al. Among authors: uwamino y. Epidemiol Infect. 2024 Jan 23;152:e24. doi: 10.1017/S0950268824000141. Epidemiol Infect. 2024. PMID: 38258464 Free PMC article.
Quantification of escape from X chromosome inactivation with single-cell omics data reveals heterogeneity across cell types and tissues.
Tomofuji Y, Edahiro R, Sonehara K, Shirai Y, Kock KH, Wang QS, Namba S, Moody J, Ando Y, Suzuki A, Yata T, Ogawa K, Naito T, Namkoong H, Xuan Lin QX, Buyamin EV, Tan LM, Sonthalia R, Han KY, Tanaka H, Lee H; Asian Immune Diversity Atlas (AIDA) Network; Japan COVID-19 Task Force; Biobank Japan Project; Okuno T, Liu B, Matsuda K, Fukunaga K, Mochizuki H, Park WY, Yamamoto K, Hon CC, Shin JW, Prabhakar S, Kumanogoh A, Okada Y. Tomofuji Y, et al. Cell Genom. 2024 Aug 14;4(8):100625. doi: 10.1016/j.xgen.2024.100625. Epub 2024 Jul 30. Cell Genom. 2024. PMID: 39084228 Free PMC article.
Cellular and humoral immune responses to COVID-19 booster vaccination in Japanese dialysis patients.
Yoshifuji A, Toda M, Oyama E, Nakayama T, Mise-Omata S, Kikuchi K, Yoshizawa M, Kato N, Wakai H, Koibuchi K, Morimoto K, Uwamino Y, Namkoong H, Shibata A, Wakabayashi K, Fujino M, Komatsu M, Mochizuki N, Kondo N, Yoshimura A, Hasegawa N, Ryuzaki M. Yoshifuji A, et al. Among authors: uwamino y. Clin Exp Nephrol. 2024 Jul;28(7):674-682. doi: 10.1007/s10157-024-02477-8. Epub 2024 Mar 8. Clin Exp Nephrol. 2024. PMID: 38457030
Factors affecting motivation for receiving a booster dose of the COVID-19 vaccine among Japanese university students and staff: a cross-sectional questionnaire survey.
Uchida S, Uno S, Kondo M, Uwamino Y, Namkoong H, Nishimura T, Misawa K, Kashimura S, Yamato K, Ishizaka T, Nagashima K, Kitagawa Y, Hasegawa N. Uchida S, et al. Among authors: uwamino y. Sci Rep. 2024 Apr 5;14(1):8009. doi: 10.1038/s41598-024-58603-9. Sci Rep. 2024. PMID: 38580716 Free PMC article.
Humoral and cellular immune response dynamics in Japanese healthcare workers up to six months after receiving a third dose of BNT162b2 monovalent vaccine.
Uwamino Y, Yokoyama T, Sato Y, Shibata A, Kurafuji T, Tanabe A, Noguchi M, Arai T, Ohno A, Yokota H, Namkoong H, Nishimura T, Kosaki K, Hasegawa N, Wakui M, Murata M, Matsushita H. Uwamino Y, et al. Vaccine. 2023 Feb 24;41(9):1545-1549. doi: 10.1016/j.vaccine.2023.01.049. Epub 2023 Jan 31. Vaccine. 2023. PMID: 36732167 Free PMC article.
Virological characteristics of the SARS-CoV-2 KP.2 variant.
Kaku Y, Uriu K, Kosugi Y, Okumura K, Yamasoba D, Uwamino Y, Kuramochi J, Sadamasu K, Yoshimura K, Asakura H, Nagashima M; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ito J, Sato K. Kaku Y, et al. Among authors: uwamino y. Lancet Infect Dis. 2024 Jul;24(7):e416. doi: 10.1016/S1473-3099(24)00298-6. Epub 2024 May 20. Lancet Infect Dis. 2024. PMID: 38782005 No abstract available.
117 results